You have 9 free searches left this month | for more free features.

immunotherapy

Showing 1 - 25 of 40

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

e-ITAG Allergen Immunotherapy in Management of Allergic Asthma

Recruiting
  • Study the Efficacy of ITA in Patients With Allergic Asthma or Allergic Rhinitis or Allergic Rhinitis Compared With Conventional Treatment
  • Immunotherapy
  • Tunis, Montfleury, Tunisia
    Military Hospital of Tunis
Aug 26, 2023

Immunotherapy in MSI-H Metastatic Colorectal Cancer

Recruiting
  • Colorectal Cancer
  • Immunotherapy
  • Carpi, Modena, Italy
    Ospedale Ramazzini
Sep 5, 2022

Locally Advanced NSCLC, Efficacy and Safety Trial in Guangzhou (Anlotinib, Chemotherapy, Radiotherapy)

Recruiting
  • Locally Advanced Non-small Cell Lung Cancer
  • Efficacy and Safety
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Jul 28, 2022

Organoid Model Predictive of Response to Immunotherapies

Recruiting
  • Breast Cancer
  • Immunotherapy
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Oct 10, 2023

ctDNA as a Biomarker for Treatment in Advanced NSCLC

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Immunotherapy
  • +2 more
  • Fuzhou, Fujian, China
    900TH Hospital of Joint Logisti'cs Support Force
Aug 2, 2022

Anti-Programmed Cell Death Protein 1 Immunotherapy in Head and

Recruiting
  • Head and Neck Cancer
  • Immunotherapy
  • Strasbourg, France
    Institut de cancérologie Strasbourg Europe
Apr 14, 2022

Locally Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer Trial in France (SRT, Immunotherapy)

Recruiting
  • Locally Advanced Non Small Cell Lung Cancer
  • Metastatic Non Small Cell Lung Cancer
  • SRT
  • Immunotherapy
  • Angers, France
  • +4 more
Apr 21, 2022

NSCLC Stage III Trial (radiotherapy, Platinum-Based Drug, Immunotherapy)

Not yet recruiting
  • Non-small Cell Lung Cancer Stage III
  • radiotherapy
  • +3 more
  • (no location specified)
Sep 10, 2023

NSCLC Trial in Chongqing (procedure, drug, radiation)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • bronchial artery interventional therapy
  • +3 more
  • Chongqing, Chongqing, China
    Daping Hospital, Third Military Medical University
May 27, 2023

sidE eFfects of ImmuNotherapy:Possible Clue to Optimize cancEr

Recruiting
  • Melanoma
  • +4 more
  • Immunotherapy
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Jan 10, 2022

Stage III NSCLC, Locally Advanced, Unresectable Trial (standard Radiotherapy, Chemotherapy, Immunotherapy)

Not yet recruiting
  • Stage III Non-small Cell Lung Cancer
  • +2 more
  • standard Radiotherapy
  • +3 more
  • (no location specified)
Oct 20, 2023

Uveal Melanoma Trial in San Francisco (stereotactic body radiotherapy, Immunotherapy)

Recruiting
  • Uveal Melanoma
  • stereotactic body radiotherapy
  • Immunotherapy
  • San Francisco, California
    California Pacific Medical Center Research Institute
Dec 2, 2022

NSCLC Trial in Rotterdam (Nutritional intervention, Immunotherapy)

Recruiting
  • Non-small Cell Lung Cancer
  • Nutritional intervention
  • Immunotherapy
  • Rotterdam, Netherlands
    Erasmus MC
Jun 5, 2023

Esophagus Cancer, Esophagogastric Junction Cancer, Chemoradiation Trial in China (Radiotherapy, Platinum based chemo, Paclitaxel

Recruiting
  • Esophagus Cancer
  • +5 more
  • Radiotherapy
  • +5 more
  • Anyang, Henan, China
  • +4 more
Aug 17, 2022

Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Metastatic Esophageal Squamous Cell Carcinoma Trial in Shanghai

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • LDRT+CFRT
  • +2 more
  • Shanghai, China
  • +1 more
Aug 3, 2023

Rectal Cancer, Radiotherapy, Immunotherapy Trial in Wuhan (Chemotherapy, Immunotherapy, IMRT)

Active, not recruiting
  • Rectal Cancer
  • +3 more
  • Wuhan, Hubei, China
    Cancer Center, Union Hospital, Tongji Medical College, Huazhong
Jun 19, 2021

Melanoma, Melanoma Stage IV, Metastatic Melanoma Trial in Gothenburg (Surgical metastasectomy, Immunotherapy)

Recruiting
  • Melanoma
  • +3 more
  • Surgical metastasectomy
  • Immunotherapy
  • Gothenburg, Sweden
    Sahlgrenska University Hospital
May 3, 2022

Muscle-Invasive Bladder Carcinoma, Oligometastatic Disease Trial (metastasis directed therapy (MDT), Immunotherapy)

Recruiting
  • Muscle-Invasive Bladder Carcinoma
  • Metastasis directed therapy (MDT)
  • +2 more
  • Ghent, Belgium
    Ghent University Hospital
Dec 3, 2022

NSCLC Stage IV, Brain Metastases, Immunotherapy Trial in Hangzhou (Immunotherapy, WBRT, Chemotherapy)

Recruiting
  • NSCLC Stage IV
  • +2 more
  • Immunotherapy
  • +2 more
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 3, 2021

Stage III NSCLC Trial in Birmingham (Adaptive Radiotherapy, Non-Adaptive Radiotherapy, Chemotherapy)

Not yet recruiting
  • Stage III Non-small Cell Lung Cancer
  • Adaptive Radiotherapy
  • +3 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 3, 2022

PD1/PDL1 Inhibitors Treatment Duration in Patients With NSCLC

Recruiting
  • Non-small Cell Lung Cancer
  • Immunotherapy
  • Monza, Italy
    ASST-Monza Ospedale San Gerardo
Jun 9, 2022

Brain Metastases, Non Small Cell Lung Cancer Trial in Durham (Stereotactic Radiosurgery, Immunotherapy)

Recruiting
  • Brain Metastases
  • Non Small Cell Lung Cancer
  • Stereotactic Radiosurgery
  • Immunotherapy
  • Durham, North Carolina
    Duke Cancer Center
Jun 6, 2022

Esophageal Squamous Cell Carcinoma Trial in Hanzhou, Ningbo (Neoadjuvant Radiotherapy, Neoadjuvant Chemotherapy, Immunotherapy)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Neoadjuvant Radiotherapy
  • +2 more
  • Hanzhou, Zhejiang, China
  • +2 more
Aug 16, 2022

Metastatic Tumor Trial in Prince George, London, Montréal (radiation, drug, other, procedure)

Not yet recruiting
  • Metastatic Tumor
  • Palliative Radiotherapy
  • +9 more
  • Prince George, British Columbia, Canada
  • +2 more
Feb 6, 2023

Esophageal Cancer, Gastroesophageal Cancer, Immunotherapy Trial in Jinan (Chemotherapy Drugs, Cancer, Immunotherapy)

Recruiting
  • Esophageal Cancer
  • +3 more
  • Chemotherapy Drugs, Cancer
  • Immunotherapy
  • Jinan, Shandong, China
    The Second Hospital of Shandong University
Dec 25, 2020